These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 15949726

  • 1. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R, Frost AE.
    J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
    [Abstract] [Full Text] [Related]

  • 2. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 3. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.
    Clin Transplant; 2005 Jun 15; 19(3):327-34. PubMed ID: 15877793
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
    Kremer BE, Reshef R, Misleh JG, Christie JD, Ahya VN, Blumenthal NP, Kotloff RM, Hadjiliadis D, Stadtmauer EA, Schuster SJ, Tsai DE.
    J Heart Lung Transplant; 2012 Mar 15; 31(3):296-304. PubMed ID: 22112992
    [Abstract] [Full Text] [Related]

  • 5. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 15; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
    Elidemir O, Kancherla BS, Schecter MG, McKenzie ED, Morales DL, Heinle JS, Mallory GB.
    Pediatr Transplant; 2009 Aug 15; 13(5):606-10. PubMed ID: 19017289
    [Abstract] [Full Text] [Related]

  • 7. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
    Wudhikarn K, Holman CJ, Linan M, Blaes AH, Dunitz JM, Hertz ME, Peterson BA.
    Clin Transplant; 2011 Aug 15; 25(5):705-13. PubMed ID: 21077949
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
    Birkeland SA, Hamilton-Dutoit S, Bendtzen K.
    Transplantation; 2003 Jul 15; 76(1):153-8. PubMed ID: 12865802
    [Abstract] [Full Text] [Related]

  • 9. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 10. Sinonasal posttransplant lymphoproliferative disorder in pediatric lung transplant patients.
    Herrmann BW, Sweet SC, Molter DW.
    Otolaryngol Head Neck Surg; 2005 Jul 01; 133(1):38-41. PubMed ID: 16025050
    [Abstract] [Full Text] [Related]

  • 11. The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases.
    Wood BL, Sabath D, Broudy VC, Raghu G.
    Cancer; 1996 Nov 15; 78(10):2223-8. PubMed ID: 8918418
    [Abstract] [Full Text] [Related]

  • 12. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.
    Herrmann BW, Sweet SC, Hayashi RJ, Canter CE, White FV, Lieu JE.
    Int J Pediatr Otorhinolaryngol; 2006 Feb 15; 70(2):303-10. PubMed ID: 16125255
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.
    Transplantation; 2007 Feb 27; 83(4):433-8. PubMed ID: 17318076
    [Abstract] [Full Text] [Related]

  • 14. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V.
    Clin Transplant; 1996 Jun 27; 10(3):248-55. PubMed ID: 8826661
    [Abstract] [Full Text] [Related]

  • 15. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 27; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 16. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.
    J Heart Lung Transplant; 1995 Oct 27; 14(2):214-21. PubMed ID: 7779838
    [Abstract] [Full Text] [Related]

  • 17. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years.
    Abe T, Ichimaru N, Kokado Y, Maeda T, Kakuta Y, Okumi M, Imamura R, Nonomura N, Isaka Y, Takahara S, Okuyama A.
    Int J Urol; 2010 Jan 27; 17(1):48-54. PubMed ID: 20002504
    [Abstract] [Full Text] [Related]

  • 19. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S, Rolla M, Cimino G, Bertasi S, Cingolani S, Scalercio F, Venuta F, Midulla F.
    J Cyst Fibros; 2005 May 27; 4(2):107-14. PubMed ID: 15914093
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 27; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.